相似文献
1
HAEMORRHAGIC DISEASES IN SURGERY. THE HAEMOSTATIC DEFECT IN HAEMOPHILIA AND ITS TEMPORARY CORRECTION.
Proc R Soc Med. 1965 Apr;58(4):251-5. doi: 10.1177/003591576505800424.
2
[TECHNIC OF TRANSFUSION THERAPY IN SURGERY ON HEMOPHILIACS].
Probl Gematol Pereliv Krovi. 1964 Aug;9:36-40.
3
THROAT AND NOSE SURGERY IN PATIENTS WITH CONSTITUTIONAL HAEMOSTATIC DEFECTS.
Proc R Soc Med. 1965 Jan;58(1):65-72. doi: 10.1177/003591576505800116.
4
[Surgery in hemophilia].
Policlinico Prat. 1969 Nov 3;76(44):1429-33.
5
Long-acting recombinant factor VIII Fc fusion protein (rFVIIIFc) for perioperative haemostatic management in severe haemophilia A.
Thromb Haemost. 2016 Jul 4;116(1):1-8. doi: 10.1160/TH15-10-0780. Epub 2016 Mar 10.
6
[Transfusion support in operations on hematophilic patients].
Probl Gematol Pereliv Krovi. 1977 Dec;22(12):7-10.
7
Correction of the haemostatic defect in haemophiliacs without apparent correction of the coagulation defect.
Haemostasis. 1974;3(3):149-57. doi: 10.1159/000214050.
8
MAJOR SURGICAL PROCEDURES, INCLUDING AMPUTATION, ON A HEMOPHILIAC.
Surgery. 1964 Feb;55:220-32.
9
Treatment of classic hemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery.
N Engl J Med. 1961 Aug 10;265:277-83 concl. doi: 10.1056/NEJM196108102650605.
10
Efficacy and safety of pegylated full-length recombinant factor VIII with extended half-life for perioperative haemostasis in haemophilia A patients.
Haemophilia. 2016 Jul;22(4):e251-8. doi: 10.1111/hae.12963. Epub 2016 Jun 21.
引用本文的文献
1
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
ILAR J. 2009;50(2):144-67. doi: 10.1093/ilar.50.2.144.
2
Hemolytic-uremic syndrome.
Indian J Pediatr. 1967 Jul;34(234):256-8.
Zotero 插件